1. Home
  2. BBNX vs KOP Comparison

BBNX vs KOP Comparison

Compare BBNX & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$10.37

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Logo Koppers Holdings Inc.

KOP

Koppers Holdings Inc.

HOLD

Current Price

$37.46

Market Cap

536.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBNX
KOP
Founded
2015
1988
Country
United States
United States
Employees
423
N/A
Industry
Medical/Dental Instruments
Forest Products
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
493.1M
536.4M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
BBNX
KOP
Price
$10.37
$37.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
$26.22
$52.50
AVG Volume (30 Days)
1.1M
207.5K
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
0.96%
EPS Growth
N/A
11.38
EPS
N/A
2.74
Revenue
N/A
$1,879,300,000.00
Revenue This Year
$34.99
$4.24
Revenue Next Year
$34.47
$0.97
P/E Ratio
N/A
$13.64
Revenue Growth
N/A
N/A
52 Week Low
$8.89
$23.54
52 Week High
$32.71
$39.27

Technical Indicators

Market Signals
Indicator
BBNX
KOP
Relative Strength Index (RSI) 25.83 62.62
Support Level N/A $26.62
Resistance Level $15.53 $39.27
Average True Range (ATR) 0.67 1.67
MACD 0.08 -0.16
Stochastic Oscillator 11.22 68.27

Price Performance

Historical Comparison
BBNX
KOP

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

About KOP Koppers Holdings Inc.

Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.

Share on Social Networks: